Strasbourg, 01/07/2003 (Agence Europe) - The European Commission adopted a communication by Commissioners Erkki Liikanen and David Byrne on Tuesday in Strasbourg, which is its response to the fourteen recommendations tabled by the G10 group (high-level group on innovation and access to medicines). With this communication on competitiveness in the pharmaceutical industry "in the interest of patients", the Commission hopes to launch a European-level discussion on promoting an integrated market...